CID 86574706

5'-gtaccgcaat-3'

Structural Information

Molecular Formula
C97H124N38O60P10
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)O)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)O
InChI
InChI=1S/C97H124N38O60P10/c1-39-19-129(96(144)124-87(39)137)64-9-41(136)51(177-64)21-168-197(149,150)192-47-14-69(131-34-112-74-79(101)106-31-109-82(74)131)183-57(47)27-175-205(165,166)194-49-16-71(133-36-114-76-81(103)108-33-111-84(76)133)184-58(49)28-173-199(153,154)188-44-12-67(128-8-5-63(100)119-95(128)143)180-55(44)25-171-204(163,164)195-50-18-73(135-38-116-78-86(135)121-92(105)123-90(78)140)186-60(50)30-176-200(155,156)189-43-11-66(127-7-4-62(99)118-94(127)142)178-53(43)23-169-198(151,152)187-42-10-65(126-6-3-61(98)117-93(126)141)179-54(42)24-170-203(161,162)193-48-15-70(132-35-113-75-80(102)107-32-110-83(75)132)185-59(48)29-174-201(157,158)190-45-13-68(130-20-40(2)88(138)125-97(130)145)181-56(45)26-172-202(159,160)191-46-17-72(182-52(46)22-167-196(146,147)148)134-37-115-77-85(134)120-91(104)122-89(77)139/h3-8,19-20,31-38,41-60,64-73,136H,9-18,21-30H2,1-2H3,(H,149,150)(H,151,152)(H,153,154)(H,155,156)(H,157,158)(H,159,160)(H,161,162)(H,163,164)(H,165,166)(H2,98,117,141)(H2,99,118,142)(H2,100,119,143)(H2,101,106,109)(H2,102,107,110)(H2,103,108,111)(H,124,137,144)(H,125,138,145)(H2,146,147,148)(H3,104,120,122,139)(H3,105,121,123,140)
InChIKey
VLAAUXYOZBGILT-UHFFFAOYSA-N
Compound name
[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] [5-(4-amino-2-oxopyrimidin-1-yl)-3-[[5-(6-aminopurin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3090.5195 Da
Monoisotopic Mass

-20.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3091.5268 283.3
[M+Na]+ 3113.5087 287.1
[M-H]- 3089.5122 284.2
[M+NH4]+ 3108.5533 284.7
[M+K]+ 3129.4827 285.2
[M+H-H2O]+ 3073.5168 283.0
[M+HCOO]- 3135.5177 285.1
[M+CH3COO]- 3149.5334 285.7
[M+Na-2H]- 3111.4942 290.7
[M]+ 3090.5190 285.0
[M]- 3090.5200 285.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.